Appointment of Chief Executive Officer and Managing Director
Filed with ASX · · 2 pages · English
Summary by 6ix AI
The announcement also notes that Andrew MacLachlan will conclude his interim role as Chief Financial Officer shortly, with Malik Jainudeen continuing as Acting CEO until Dr. Atkinson starts. The filing outlines the material terms of Dr. Atkinson's employment agreement, including her remuneration and incentives.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Monash IVF
- S&P DJI Announces September 2025 Quarterly Rebalance
- FY25 MVF Results Announcement
- MVF FY25 Appendix 4E and Financial Report
- FY25 Results Announcement
- Independent Review into Incidents completed
Later from Monash IVF
- 2025 AGM - Chair Address
- 2025 AGM - Investor Presentation
- Monash IVF rejects NBIO proposal to acquire MVF
- NBIO withdrawn to acquire Monash IVF
- 1H26 Appendix 4D and Financial Report
Follow Monash IVF into a list and get an email when it puts out news.
Follow Monash IVF